Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.
about
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THCThe cannabinoid acids, analogs and endogenous counterpartsQuantitative analysis of five tobacco-specific N-nitrosamines in urine by liquid chromatography-atmospheric pressure ionization tandem mass spectrometry.A fast method for screening and/or quantitation of tetrahydrocannabinol and metabolites in urine by automated SPE/LC/MS/MS.Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library searchTemporal indication of cannabis use by means of THC glucuronide determination.In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.Effect of hydrolysis on identifying prenatal cannabis exposureSimultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administrationIn vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents.Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices.Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds.Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletesA semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood.Comparison of LUCIO®-direct ELISA with CEDIA immunoassay for 'zero tolerance' drug screening in urine as required by the German re-licensing guidelines.Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.A review of methods for the chemical characterization of cannabis natural products.A novel fast method for aqueous derivatization of THC, OH-THC and THC-COOH in human whole blood and urine samples for routine forensic analyses.Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
P2860
Q24634909-203EABD3-3962-4D2B-AE9B-C45F56B04045Q27009735-F81D6038-794C-4127-9C21-2C80DFD399D1Q33459509-BB7CDDC1-3A4A-4E04-B0DB-F55B3C083A46Q33617835-32C9C714-56A7-4C09-ABFD-8AF81A6CDFC8Q33770190-CF866CBA-525F-4970-A6A6-89BB1FD41C93Q34607414-385E6B6B-36FC-4580-B108-A1E52E50CE52Q34618371-52631404-9F28-4DFC-A377-C790F0C91C33Q34655618-7D66BA6A-3034-4A66-87EC-9F5646502045Q35173356-DD28265E-B4FE-4C86-8531-8BA23B1BF0E8Q35175994-CD3555C5-F288-4810-A46F-8C842ECA3783Q35184670-894DE47F-16A4-403A-89B0-82AA73C4B524Q36288355-79BCF1A0-4885-4B5A-AE8E-A823347E8990Q36987924-9276AB30-14F7-4C96-88A5-CCF63E7465A7Q37029480-8D553793-01B3-4C0D-A1B2-F671E83CFD94Q37351687-14FC632B-08DE-499B-992A-61F6EE5228A6Q37389692-A2F7A36F-923B-47A5-8D2A-8F56B889ABCBQ37922114-3AE4FEAA-96F3-4D91-9CD7-0CDDA0A0C5EBQ38161854-56EAB56A-A4F2-41BB-A14F-AF4A4C8FA739Q38785676-9A097518-06EA-43A3-A91C-110F9B48E6E6Q43181133-DBC3B5C3-7BAF-4753-BE40-A54EFB5C594EQ45920899-05A5249D-F768-44C9-AECF-428D7CAF5B7FQ46856349-EC973B83-59C9-4AEE-A0CC-2B58733826B7Q47294789-BFF61DED-8C03-48E9-ABB6-81980A3E91B2Q48229288-8C8B3A08-EA33-4DEC-8182-4C8FF956BF5BQ48308510-7F126902-FF5E-4684-9782-E98A27BEFE08Q54243217-125EBDDB-C3A4-433C-9D39-529934509FC5
P2860
Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Simultaneous GC-EI-MS determin ...... em enzyme-alkaline hydrolysis.
@en
Simultaneous GC-EI-MS determin ...... em enzyme-alkaline hydrolysis.
@nl
type
label
Simultaneous GC-EI-MS determin ...... em enzyme-alkaline hydrolysis.
@en
Simultaneous GC-EI-MS determin ...... em enzyme-alkaline hydrolysis.
@nl
prefLabel
Simultaneous GC-EI-MS determin ...... em enzyme-alkaline hydrolysis.
@en
Simultaneous GC-EI-MS determin ...... em enzyme-alkaline hydrolysis.
@nl
P2093
P2860
P356
P1476
Simultaneous GC-EI-MS determin ...... em enzyme-alkaline hydrolysis.
@en
P2093
Ross H Lowe
Stephane O Pirnay
Tsadik T Abraham
William D Darwin
P2860
P304
P356
10.1093/JAT/31.8.477
P577
2007-10-01T00:00:00Z